Anest. intenziv. Med. 2018;29(3):168-170

"Zdánlivá smrt" - je z pohledu fyziologie možná?Postgraduate education - Selected Topics in Clinical Physiology

Škulec R.1,2,3, V. Černý1,2,4,5,*
1 Klinika anesteziologie, perioperační a intenzivní medicíny, Univerzita J. E. Purkyně a Masarykova nemocnice v Ústí nad Labem
2 Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta v Hradci Králové, Univerzita Karlova, Fakultní nemocnice Hradec Králové
3 Zdravotnická záchranná služba Středočeského kraje, Kladno
4 Centrum pro výzkum a vývoj, Fakultní nemocnice Hradec Králové
5 Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Kanada

Received: April 25, 2018; Accepted: April 30, 2018; Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Škulec R, Černý V. "Zdánlivá smrt" - je z pohledu fyziologie možná? Anest. intenziv. Med. 2018;29(3):168-170.
Download citation

References

  1. Via MA, Gallagher EJ, Mechanick JI. Bone physiology and therapeutics in chronic critical illness. Ann N Y Acad Sci [Internet]. 2010[cited 2017 Jan 28];1211:85-94. Go to original source... Go to PubMed...
  2. Lee P, Nair P, Eisman JA, et al. Bone Failure in Critical Illness. Crit Care Med [Internet]. 2016[cited 2017 Jan 29];44:2270-2274. Go to original source... Go to PubMed...
  3. http://www.bbc.com/news/world-asia-india-40509494
  4. Orford NR, Lane SE, Bailey M, et al. Changes in Bone Mineral Density in the Year after Critical Illness. Am J Respir Crit Care Med [Internet]. 2016[cited 2017 Jan 28];193:736-744. Go to original source... Go to PubMed...
  5. Lee P, Ng C, Slattery A, et al. Preadmission Bisphosphonate and Mortality in Critically Ill Patients. J Clin Endocrinol Metab [Internet]. 2016[cited 2017 Jan 28];101:1945-1953. Go to original source... Go to PubMed...
  6. Schulman RC, Moshier EL, Rho L, et al. Intravenous pamidronate is associated with reduced mortality in patients with chronic critical illness. Endocr Pract [Internet]. 2016[cited 2017 Jan 28];22:799-808. Go to original source... Go to PubMed...
  7. Via MA, Potenza MV, Hollander J, et al. Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness. J Intensive Care Med [Internet]. 2012[cited 2017 Jan 28];27:312-318. Go to original source... Go to PubMed...
  8. Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA [Internet]. 2014[cited 2017 Jan 29];312:1520-1530. Go to original source... Go to PubMed...
  9. Kutcher ME, Forsythe RM, Tisherman SA. Emergency preservation and resuscitation for cardiac arrest from trauma. Int J Surg. 2016;33(PtB):209-212. Go to original source... Go to PubMed...
  10. Látalová K, Praško J, Maršálek M. Varianty katatonie. Česk Slov Neurol N. 2009;72/105:518-524.
  11. Quinn DK, Abbott CC. Catatonia after cerebral hypoxia: do the usual treatments apply? Psychosomatics. 2014;55:525-535. Go to original source... Go to PubMed...
  12. Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016;6:391-398. Go to original source... Go to PubMed...
  13. Kuisma M, Salo A, Puolakka J, et al. Delayed return of spontaneous circulation (the Lazarus phenomenon) after ces-sation of out-of-hospital cardiopulmonary resuscitation. Resuscitation. 2017;118:107-111. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.